Nieuws

Chiesi’s 2022 Sustainability Report: “Purpose First”

With the publication of Chiesi's Sustainability Report, Maria Paola Chiesi, Chiesi's Vice Chair and Head of Shared Value & Sustainability, sheds light on the company's sustainability initiatives...

1/19

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

2/19

2022 for Chiesi: The Group’s international growth continues

3/19

ARCHIEF

Chiesi Group and Affibody collaborate to develop and commercialize innovative treatments for respiratory diseases

14 March 2023 Nieuws

Chiesi appoints Giuseppe Accogli as new Group CEO

01 February 2023 Nieuws

Chiesi accelerates path toward full sustainability despite Covid-19 pandemic

23 June 2021 Nieuws

Wereld Astma Dag 2021: Persbericht

05 May 2021 Nieuws

CHIESI CONTINUES CULTURAL TRANSFORMATION WITH NEW VISUAL IDENTITY THAT MIRRORS PATIENTS’ LANGUAGE AND EXPERIENCES

22 March 2021 Nieuws

Chiesi Group: performance is up in 2020

09 March 2021 Nieuws

Europese marktautorisatie voor de extrafijne drievoudige combinatietherapie

05 February 2021 Nieuws

SAMENWERKING TUSSEN KAIA HEALTH EN DE CHIESI GROEP

30 November 2020 Nieuws

COPD Dag 2020

17 November 2020 Nieuws

Samenwerking tussen Moderna en de Chiesi Groep

17 September 2020 Nieuws

10 Jaar Chiesi België

02 September 2020 Nieuws

Chiesi publishes its annual report

23 July 2020 Nieuws

Climbing For Life

09 June 2020 Nieuws

Zondag 31 mei - Werelddag zonder tabak

30 May 2020 Nieuws

Domus Medica

07 April 2020 Nieuws

Chiesi België & COVID-19 Pandemic

03 April 2020 Nieuws

Telecomlaan / Avenue Telecom 9 PO Box 4 1831 Diegem
Belgium
T +32 (0)2 788 42 00
info.be@chiesi.com
Approval n°: 1381/TCP/InfoBrochure/BE/03-2023
Laatste update: 17/05/2023

CHIESI ON THE WEB